EMDeviceLab
@EMDeviceLab
Medical Device Company making abscess treatment better, one patient at a time.
Talvez você curta
Thanks to our friends who are dedicated to emergency medicine! The theme of Emergency Medicine Day is, "Your Safety, Our Priority." We support the initiatives to help increase the safety of all in EM. #emergencymedicineday #emergencymedicine #emergencydepartment #emergencycare
On November 17, #CTIP portfolio member, @EMDeviceLab will be showcased in Wound Care Startup Demo Day presented by Innovation Lab! Learn more: ed.gr/edp6w #medtech #innovation
Matt Wilkinson, our CCO, was featured on ACEP Frontline with @EverydayMed where they discuss why the loop technique for abscess treatment is the new gold standard, and why the Quickloop provides fast and reliable loop drainage. #acep #emergencymedicine on.soundcloud.com/Fvfdm
We appreciate all the support @westcoastctip provides developing stage companies who are building devices serving the unique needs of pediatric patients.
. #CTIP portfolio member, @EMDeviceLab, has developed Quickloop, a #medical #device that simplifies a novel technique for the incision and drainage of cutaneous abscesses. Interested in learning about EM Device Lab founded by emergency physicians? Visit: ed.gr/d701e
Dr. Mark Rosenberg Joins EM Device Lab Board of Advisors emdevicelab.com/press-releases…
Green Room Technologies's friend @EMDeviceLab Inc. is featured in #EmergencyPhysiciansMonthly article on #MedicalDevice Innovation. bit.ly/3E3blaR
We are pleased to announce that the Quickloop Abscess Treatment Device is now available for sale in the US! Click on the link below to read more about it, and learn how to try the newest, and best way to treat an abscess! hubs.ly/H0Txnn90
Congratulations to #TNVC2020 and #TNVC2019 competitor @EMDeviceLab for their new U.S. patent! They have developed a device for treating abscesses, follow this post to learn more about their treatment! emdevicelab.com/press-releases…
Thank you so much for the kind words from @EMDeviceLab "We are so thankful to the organizers and sponsors of TNVC and we're proud to have been awarded two prizes and meet potential investors. As a result, we will be able to accelerate our product launch. Great event!"
We are so pleased to win the BioTex Investment prize at #TNVC2020!
Proud to win the Amerra Visualization Services Prize at #TNVC2020! Thanks @AmerraMedical!
Congratulations to @EMDeviceLab for winning the Amerra Visualization Services Prize sponsored by @AmerraMedical
We are so excited to announce we will be competing in the #TNVC2020 competition! Thanks to @Texas A&M New Ventures Competition for this opportunity.
Raising an investment round in this environment is challenging and would normally be a time to back off. However, we have a product intended to eliminate up to 6 million patient visits per year in US health care facilities. Learn more here. youtu.be/hK5iQrAUIpk via @YouTube
We finished 2019 strong and are looking forward to a great 2020. Please read about it here. mailchi.mp/4a66a06b3292/q…
EM Device awarded the Pediatric Prize at the Texas A&M New Ventures Competition! Thanks to the Southwest National Pediatric Device Consortium and @Texasnvc! #tnvc2019 SWPDC.org
Thanks, @TempleHBD team! We are proud to be awarded 2nd place.
On the heels of last week's successful annual conference and pitch competition, we extend thanks to all of our participants and expert speakers. Get the inside scoop on the #conference and competition winners via @tdtnews. buff.ly/2V9xqNa #ChooseTemple #biotech #medtech
Proud to be a semi-finalist!
United States Tendências
- 1. #HardRockBet N/A
- 2. Alex Pretti N/A
- 3. Yoshi N/A
- 4. Gannon N/A
- 5. #OlandriaxHauteCoutureSS26 N/A
- 6. Laken Riley N/A
- 7. Todd Blanche N/A
- 8. Good Sunday N/A
- 9. Championship Sunday N/A
- 10. Kyle Rittenhouse N/A
- 11. #HauteCoutureWeek N/A
- 12. Estevao N/A
- 13. #ARSMUN N/A
- 14. Leonhard N/A
- 15. #tspotter N/A
- 16. Oviedo N/A
- 17. Birdo N/A
- 18. Muhammad Qasim N/A
- 19. Mouser N/A
- 20. Wes Moore N/A
Something went wrong.
Something went wrong.